Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

AbSci Announces Strategic Investment

2021-02-22
VANCOUVER, WA, AbSci announced a strategic equity investment by Merck Global Health Innovation Fund.
AbSci, a synthetic biology company, announced a strategic equity investment by Merck Global Health Innovation Fund (Merck GHI) and potential discovery collaborations with Merck Research Laboratories.

AbSci is a leading synthetic biology company that translates ideas into drugs with a revolutionary platform technology that reinvents the biopharmaceutical drug discovery process.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors